Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody

在登革病毒样颗粒疫苗制剂上进行表位重塑,以诱导产生广谱中和抗体

阅读:7
作者:Wen-Fan Shen # ,Jedhan Ucat Galula # ,Jyung-Hurng Liu # ,Mei-Ying Liao # ,Cheng-Hao Huang ,Yu-Chun Wang ,Han-Chung Wu ,Jian-Jong Liang ,Yi-Ling Lin ,Matthew T Whitney ,Gwong-Jen J Chang ,Sheng-Ren Chen ,Shang-Rung Wu ,Day-Yu Chao #

Abstract

Dengue fever is caused by four different serotypes of dengue virus (DENV) which is the leading cause of worldwide arboviral diseases in humans. Virus-like particles (VLPs) containing flavivirus prM/E proteins have been demonstrated to be a potential vaccine candidate; however, the structure of dengue VLP is poorly understood. Herein VLP derived from DENV serotype-2 were engineered becoming highly matured (mD2VLP) and showed variable size distribution with diameter of ~31 nm forming the major population under cryo-electron microscopy examination. Furthermore, mD2VLP particles of 31 nm diameter possess a T = 1 icosahedral symmetry with a groove located within the E-protein dimers near the 2-fold vertices that exposed highly overlapping, cryptic neutralizing epitopes. Mice vaccinated with mD2VLP generated higher cross-reactive (CR) neutralization antibodies (NtAbs) and were fully protected against all 4 serotypes of DENV. Our results highlight the potential of 'epitope-resurfaced' mature-form D2VLPs in inducing quaternary structure-recognizing broad CR NtAbs to guide future dengue vaccine design. Keywords: broad antibody response; cryoEM; dengue; infectious disease; microbiology; molecular biophysics; mouse; structural biology; vaccine; virus; virus-like particle.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。